Clinical Trial Update: A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Faricimab treatment response in treatment-naive, underrepresented patients with Diabetic Macular Edema; currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Faricimab (faricimab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Diabetic Macular Edema | Phase 4 | Status: ACTIVE_NOT_RECRUITING